Kenneth Clark
Director/Board Member at SUMMIT THERAPEUTICS INC.
Net worth: - $ as of 31/05/2024
Profile
Kenneth A.
Clark is currently a Non-Executive Director at Summit Therapeutics Ltd., a Lead Independent Director at Summit Therapeutics, Inc., a Director at Acurex Biosciences Corp., and a Partner at Wilson Sonsini Goodrich & Rosati PC.
Previously, he served as an Independent Director at Pharmacyclics LLC from 2012 to 2015 and at Pulse Biosciences, Inc. from 2017 to 2021.
Mr. Clark obtained his undergraduate degree from Vanderbilt University and his graduate degree from The University of Texas at Austin.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SUMMIT THERAPEUTICS INC
-.--% | 17/04/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Kenneth Clark active positions
| Companies | Position | Start |
|---|---|---|
| SUMMIT THERAPEUTICS INC. | Director/Board Member | 07/10/2021 |
Wilson Sonsini Goodrich & Rosati PC
 Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Wilson Sonsini Goodrich & Rosati PC provides legal services. Its services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Director/Board Member | - |
Former positions of Kenneth Clark
| Companies | Position | End |
|---|---|---|
| PULSE BIOSCIENCES, INC. | Director/Board Member | 05/10/2021 |
| PHARMACYCLICS, INC. | Director/Board Member | 01/05/2015 |
Training of Kenneth Clark
| Vanderbilt University | Undergraduate Degree |
| The University of Texas at Austin | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PULSE BIOSCIENCES, INC. | Health Technology |
| SUMMIT THERAPEUTICS INC. | Health Technology |
| Private companies | 3 |
|---|---|
Wilson Sonsini Goodrich & Rosati PC
Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Wilson Sonsini Goodrich & Rosati PC provides legal services. Its services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Commercial Services |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Kenneth Clark
